1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Aimfinity Investment Corp. I

Aimfinity Investment Corp. I

AIMBU
Aimfinity Investment Corp. IUS flagNASDAQ Global Select
18.15
USD
+1.15
- -
220,268.00Market Cap
Aimfinity Investment Corp. I
AIMBU
(NASDAQ Global Select)

Recent

price

18.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
2
1
1
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-2
-3
-4
Working Capital
- -
- -
- -
- -
- -
LT Debt
- -
80
39
31
7
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
3.21
3.47
3.59
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
2
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
4
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
3
4
Payables & Accruals
1
1
1
ST Debt
2
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-21.54%
Free Cash Flow
- -
- -
-44.31%
Net Income, GAAP
- -
- -
-36.46%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Legato Merger Corp. II (LGTOU)
Orion Biotech Opportunities Corp. (ORIA)
Mining, Minerals & Metals plc (MMM.L)
Tailwind 2.0 Acquisition Corp. Rights (TDWDR)
Tuscan Holdings Corp. (THCB)
Talon Capital Corp. (TLNCU)
Business
Aimfinity Investment Corp. I operates as a special purpose acquisition company dedicated to achieving a business combination, such as a merger, share exchange, asset acquisition, or similar transaction, with one or more enterprises. It strategically targets technology and tech-enabled ventures within sectors like consumer internet, e-commerce, software, cloud computing, healthcare, transportation/mobility, financial services, and hospitality. Established in 2021 and based in New York, New York, the firm functions as a subsidiary of Aimfinity Investment LLC. The company's shareholders recently approved its proposed business combination with Docter Inc., a Taiwanese health technology firm specializing in non-invasive blood glucose monitoring. Following a notice from Nasdaq, Aimfinity's securities transitioned to trading on the OTC Markets as of May 2025, though it continues to work towards securing a Nasdaq listing for the combined entity. The deadline for completing this business combination has been extended multiple times, with provisions allowing further monthly extensions into 2026.